Cee Dee Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 15-11-2024
- Paid Up Capital ₹ 1.00 M
as on 15-11-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.65 M
as on 15-11-2024
- Revenue -44.47%
(FY 2023)
- Profit -84.18%
(FY 2023)
- Ebitda -63.49%
(FY 2023)
- Net Worth 4.80%
(FY 2023)
- Total Assets 17.42%
(FY 2023)
About Cee Dee Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.65 M.
Sanjay Gupta, Sheikh Abdullah, and Ayesha Sheikh serve as directors at the Company.
- CIN/LLPIN
U85100DL2011PTC217894
- Company No.
217894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2011
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cee Dee Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gupta  | Director | 20-Apr-2011 | Current |
| Sheikh Abdullah | Director | 20-Apr-2011 | Current |
| Ayesha Sheikh | Director | 20-Apr-2011 | Current |
Financial Performance of Cee Dee Diagnostics.
Cee Dee Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.47% decrease. The company also saw a substantial fall in profitability, with a 84.18% decrease in profit. The company's net worth moved up by a moderate rise of 4.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cee Dee Diagnostics?
In 2023, Cee Dee Diagnostics had a promoter holding of 65.73% and a public holding of 34.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Orbit Scan & Pathlab Private LimitedActive 11 years 1 monthSheikh Abdullah and Ayesha Sheikh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jan 2023 | ₹3.65 M | Open |
Siemens Financial Services Private Limited Creation Date: 23 Jul 2012 | ₹1.00 M | Open |
How Many Employees Work at Cee Dee Diagnostics?
Cee Dee Diagnostics has a workforce of 1 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cee Dee Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cee Dee Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
